Abstract
This study examined whether level of exposure to Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), a 12-Step facilitative therapy, is related to treatment outcome. Data were from a large National Drug Abuse Treatment Clinical Trials Network (CTN) study comparing STAGE-12 combined with treatment-as-usual (TAU) to TAU alone. These analyses include only those randomized to STAGE-12 (n= 234). Assessments occurred at baseline and 30, 60, 90, and 180. days following randomization. High-exposure patients (n= 158; attended at least 2 of 3 individual, and 3 of 5 group, sessions), compared to those with less exposure (n= 76), demonstrated: (1) higher odds of self-reported abstinence from, and lower rates of, stimulant and non-stimulant drug use; (2) lower probabilities of stimulant-positive urines; (3) more days of attending and lower odds of not attending 12-Step meetings; (4) greater likelihood of reporting no drug problems; (5) more days of duties at meetings; and (6) more types of 12-Step activities. Many of these differences declined over time, but several were still significant by the last follow-up. Treatment and research implications are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 265-274 |
Number of pages | 10 |
Journal | Journal of Substance Abuse Treatment |
Volume | 47 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2014 |
Keywords
- 12-Step
- 12-Step facilitation
- Cocaine
- Intensive referral
- Methamphetamine
- Treatment exposure
ASJC Scopus subject areas
- Phychiatric Mental Health
- Medicine (miscellaneous)
- Clinical Psychology
- Psychiatry and Mental health